Assay

#Assay #Biologics / Biotechnology #Biopharma #Diversity #DNA #Drug development #Drug discovery #Gene sequencing #Ingredients / APIs / Fine chemicals #Synthetic biology #Women in Discovery #Women in STEM

New podcast: Overcoming different barriers in drug discovery

This is the latest episode of the free DDW narrated podcast, “Overcoming different barriers in drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Addressing the challenge of salt forms in drug discovery”, “… Read More

#News

Scientist looking through microscope
#Assay #Biologics / Biotechnology #Biopharma #Drug development #Ingredients / APIs / Fine chemicals

Addressing the challenge of salt forms in drug discovery

Listen to this article on the DDW Podcast: Some 5% of commercially available research compounds are sold as salt forms. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability. By selecting the correct salt form for an assay or as a… Read More

#Exclusive Content #Opinion

#Assay #Whitepaper

Learn about viral titer and quality in this whitepaper

This whitepaper brought to you by Mirus Bio details the multiple approaches developers can use to verify the quality and functionality of viral assays. Download the latest Mirus Bio whitepaper to learn about: Methods to characterize lentivirus and adeno-associated virus Differences between physical and functional assays of virus How to… Read More

#News

#Assay #Covid-19 #Monkeypox

This week in drug discovery (27 – 30 June)

News round-up by DDW’s Reece Armstrong for 27 – 30 June. Assays for monkeypox, Covid-19 boosters and approvals for oncology drugs are some of the themes of this week’s news round-up. GSK & Sanofi first to report positive data for Omicron booster   GSK and Sanofi have reported positive efficacy… Read More

#News

#Assay #Immunology / Virology & Vaccines #Monkeypox

Novacyt launches monkeypox assay in response to outbreak  

Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries.   The company’s monkeypox assay is for research-use only (RUO) and has been developed in two forms for the detection of the virus genome in… Read More

#News

#Assay #Stem cells

Axol Bioscience introduces stem cells for cardiotoxicity  

Life sciences provider Axol Bioscience has announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation. By using this assay, Axol was able to show that the cells were suitable for measuring cardiotoxicity, offering scientists a robust cardiac… Read More

#News

#Assay #CRO #Funding #Technology

Gentronix set to double in size following £700k investment 

Gentronix, a UK-based contract research organisation (CRO) working in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.  The latest round, which includes a number of private investors, follows Gentronix’s recent acquisition of the Big Blue transgenic mutation… Read More

#News

#AI / data analytics / healthtech / informatics #Assay #Drug discovery #Electronic Lab Notebooks (ELN) #Research #Screening

Digitalisation of VIB’s biomedical research with CDD Vault 

This paid-for advertorial by CDD Vault appeared in the DDW / ELRIG UK Drug Discovery 2021 supplement in DDW Volume 22, Issue 4 – Fall 2021   For any research-based organisation in the life sciences arena, experimental data is the key to deriving biological and biochemical insight and understanding,… Read More

#Exclusive Content

#Assay #Bioscience #Drug development #Kinetics #Video

Re-energise your kinase discovery programme

Using Promega’s NanoBRET technology, scientists at Aurelia Bioscience have implemented intracellular kinase assays designed to study the interaction of compounds on kinase targets in intact living cells. Advantages of this technique include examination of compound binding to target kinases at physiological ATP concentrations, expression of full-length kinase target… Read More

#Videos

#Assay #Bioscience #Data #Drug discovery #Drug targets #Interview #Life sciences #Screening

Ask the expert: assisting researchers with hit-to-lead

Pelago Bioscience is a specialised CRO, focusing on its patented Cellular Thermal Shift Assay (CETSA), which can assess therapeutically relevant target engagement in cells or tissue of unmodified compounds against the native, full-length proteins of interest. Stina Lundgren, Principal Project Advisor, shared the company’s hit-to-lead expertise with Lu Rahman. CETSA… Read More

#Editor's Choice #Exclusive Content #News

#Assay #Drug development #Drug toxicity #Preclinical development #Toxicology

Enhancing the predictability of drug toxicity and efficacy

There is an unmet clinical need in drug development for in vitro models that reduce the risk of drug-induced toxicity and late-stage drug attrition. In this webinar, hosted on May 26 2021, two expert speakers discuss how researchers can enhance the predictability of pre-clinical drug development. This webinar, Enhancing the predictability of… Read More

#Editor's Choice #News

#Assay #Assay development optimisation & technology #Covid-19 #Drug development #Immunology / Virology & Vaccines #Reagents

The Native Antigen Company launches assay development kit

The Native Antigen Company has announced the launch of its SARS-CoV-2 Neutralisation Assay Development Kit. The kit can be used to identify and qualitatively assess the ability of antibodies to neutralise SARS-CoV-2-receptor binding, to support research into variants and their effects on natural and vaccine-induced patient immunity. The kit contains… Read More

#News

#Assay #Biotechnology #Drug development #Drug discovery #Screening

Molecular Devices opens Organoid Innovation Centre

Molecular Devices has opened an Organoid Innovation Centre at the company’s global headquarters in California. The centre expands beyond imaging to demonstrate an end-to-end solution that addresses challenges associated with the sample prep-to-report pipeline for assays performed on complex 3D biological models. On display are methods and technologies to test… Read More

#News

#Assay #Bioscience #Biotechnology #Drug development #Kinetics #Research #Screening #Video

NanoBRET technology enables the study of the interaction of compounds

Aurelia Bioscience is a pre-clinical contract research organisation specialising in bioassay development, pharmacological profiling and compound screening. Scientists at Aurelia Bioscience have experience developing new and innovative bio-assays for different target classes using technologies to deliver client projects in a timely, efficient and cost-effective manner. Using Promega’s NanoBRET… Read More

#News #Videos

#Assay #Assay development optimisation & technology #Drug discovery #Research

BellBrook Labs given NIH funding for work on antitumour immunity 

Drug discovery company BellBrook Labs has been awarded a $300,000 Phase I Small Business Innovative Research grant to develop and validate HTS assays for the discovery of small-molecule antagonists of TREX1. Immunotherapy approaches such as immune checkpoint blockade are said to be transforming oncology. However, many patients do not respond to… Read More

#News